Common Use | Ginkgolide B (BN-52021), an important active terpenoid from Ginkgo biloba leaves, is reported to increase cell viability and decrease cell apoptosis. IC50 value: Target: In vitro: Ginkgolide B (0.2 or 0.4 μg/ml) was added to the culture medium in vitro led to increases in cell viability and decreases in the number of hippocampal cells undergoing AAPH-induced apoptosis. Ginkgolide B caused a dose-related protection against dysrhythmias; the antiarrhythmic effect of ginkgolide B was comparable to that of diltiazem and superior to the activity of metoprolol. Ginkgolide B can presumably prevent the re-entry mechanism involved in the development of ischemia-induced rhythm disturbances. In vivo: Oral administration of ginkgolide B (2 mg/kg/day, p.o.) caused a significant increase in cell viability and a highly significant decrease in the numbers of both spontaneously occurring and AAPH-induced apoptoses |
Structure | |
Purity | ≥98% |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 year. In solvent: -80 °C, 2 years; -20 °C, 1 year |
Molecular Weight | 424.4 |
Molecular Formula | C20H24O10 |
CAS No. | 15291-77-7 |
Appearance | Solid |
Solubility | Soluble in DMSO |
Catalog: CDPE23-038-L
Catalog: CDPE23-030-L
Catalog: CDPE23-003-L
Catalog: CDPE23-046-L
Catalog: CDPE23-007-L
Catalog: CDPE23-019-L
Catalog: CDPE23-027-L
Catalog: CDPE23-056-L
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.